Aysel Ozpinar | Biochemistry, Genetics and Molecular Biology | Research Excellence Award

Research Excellence Award

Aysel Ozpinar — Acibadem University
Aysel Ozpinar
Affiliation Acibadem University
Country Turkey
Scopus ID 6602895292
Documents 88
Citations 1,315
h-index 23
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Research Scientist Awards

The Research Excellence Award article presents an academic overview of Aysel Ozpinar, a researcher affiliated with Acibadem University, Turkey, whose scholarly work in molecular biology, genetics, and biochemical sciences has contributed to the advancement of translational and interdisciplinary biomedical research. The evaluation presented herein is based on publicly accessible academic metrics, indexed publications, citation analyses, and internationally recognized researcher identification systems.[1][2]

Abstract

This article examines the academic accomplishments, publication record, citation performance, and broader scientific influence of Aysel Ozpinar. The profile reflects sustained research productivity across biochemical and molecular biological disciplines, with measurable scholarly influence demonstrated through international indexing systems, bibliometric indicators, and collaborative scientific outputs.[1]

Keywords

  • Research Excellence
  • Biochemistry
  • Genetics
  • Molecular Biology
  • Academic Recognition

Introduction

Recognition through international scientific awards commonly considers publication output, citation impact, mentorship, interdisciplinary collaborations, and contributions to scientific advancement. Within this framework, Aysel Ozpinar demonstrates an established research portfolio aligned with globally recognized academic standards.[2]

Research Profile

The researcher is affiliated with Acibadem University in Turkey and maintains an indexed scholarly identity through Scopus and ORCID platforms. The recorded bibliometric indicators include 88 indexed documents, 1,315 citations, and an h-index of 23, indicating both productivity and sustained citation visibility within the biomedical sciences.[1]

Research Contributions

  • Molecular biomarker research
  • Genomic and proteomic investigations
  • Translational biomedical studies
  • Clinical biochemistry collaborations
  • Interdisciplinary scientific mentoring

Publications

Selected scholarly outputs include publications indexed within major international databases and journals. Representative digital object identifiers demonstrate accessibility and citation interoperability across academic platforms.[3]

Research Impact

Bibliometric evaluation indicates consistent citation accumulation, cross-disciplinary engagement, and measurable academic influence across biomedical research communities. The citation count and h-index collectively suggest continued relevance of published findings in subsequent scientific investigations.[1]

Award Suitability

Based on bibliometric performance, international researcher identification, publication continuity, and interdisciplinary contribution, the research profile demonstrates compatibility with the evaluation criteria commonly associated with the International Research Scientist Awards.[4]

Conclusion

Aysel Ozpinar represents an established academic contributor in biochemistry, genetics, and molecular biology. The combination of publication productivity, citation influence, international visibility, and scientific engagement provides a comprehensive foundation for recognition within international research award frameworks.

References

  1. Elsevier. (n.d.). Scopus author details: Aysel Ozpinar, Author ID 6602895292. Scopus.https://www.scopus.com/
  2. ORCID. (n.d.). Researcher profile of Aysel Ozpinar. ORCID Registry.https://orcid.org/0000-0002-7399-4929
  3. Crossref. (n.d.). Digital object identifier records for indexed biomedical publications.https://doi.org/
  4. International Research Scientist Awards. (n.d.). Award criteria and nomination framework.https://researchscientist.net/

Ms Raya Yashooa | Molecular biology, Genetics, Neuroscience, Cancer Research | Best Researcher Award

Ms Raya Yashooa | Molecular biology, Genetics, Neuroscience, Cancer Research | Best Researcher Award

Lecture Department of Biology, College of Education for Pure Science, at University of Al-Hamdaniya ,Iraq

Raya Khalid Yousif is an Iraqi molecular biologist with extensive expertise in microbiology, genetics, and laboratory research. With over a decade of experience in medical laboratory sciences, she is a lecturer, researcher, and skilled laboratory specialist. She has contributed significantly to Alzheimer’s disease research, infectious disease studies, and microbiological diagnostics.

Profile

orcid

scopus

Early Academic Pursuits 📚

Born on December 22, 1991, in Erbil, Iraq, Raya Khalid Yousif embarked on an academic journey driven by curiosity and dedication to the biological sciences. She earned her Bachelor of Science in Biology from the University of Baghdad in 2013, securing a distinguished sixth-ranking position. Her passion for molecular biology led her to pursue a Master of Science in Molecular Biology at Salahaddin University, Erbil, which she successfully completed in 2023. Further strengthening her academic expertise, she attended a Pedagogy course at the Lebanese French University in 2023, enhancing her teaching and research methodologies.

Professional Endeavors 🔬

With over a decade of experience in molecular biology and laboratory sciences, Raya has contributed significantly to both academia and applied research. Since February 2024, she has been serving as a Lecturer in Medical Microbiology at Knowledge University on a part-time basis. Alongside her academic role, she has been a volunteer researcher at the General Directorate of Scientific Research Center, Salahaddin University-Erbil, since April 2023, demonstrating her commitment to advancing scientific knowledge.

Her expertise extends to laboratory work, having served as a Laboratory Assistant at Catholic University-Erbil (2021-2022) and working at the Ankawa Specialized Laboratory for over a decade. These experiences have honed her practical skills in molecular diagnostics, microbiology, and clinical research.

Contributions and Research Focus 🔎

Raya Khalid Yousif specializes in molecular biology techniques, including RNA/DNA extraction, primer design, Real-Time qPCR, conventional PCR, gene cloning, and ELISA-based diagnostics. Her research has covered diverse areas such as neuroscience, oncology, genetics, molecular immunology, bacteriology, and clinical hematology. Her expertise in bioinformatics tools like NCBI, Primer3 Input, and Genome Browser enables her to conduct cutting-edge genetic analysis and molecular diagnostics.

She has played a pivotal role in multiple research projects, working extensively with histopathology, bacterial culture analysis (VITEK), and immunoassay techniques. Her work in diagnostic microbiology has contributed to advancements in disease detection and therapeutic strategies, particularly in neurological and infectious diseases.

Accolades and Recognition 🏅

Raya’s contributions to scientific research have been widely recognized. She received a Certificate of Appreciation from the General Directorate of Scientific Research Center, Salahaddin University-Erbil, in 2024 for her valuable contributions. Additionally, she has been an active manuscript reviewer for esteemed journals such as the Journal of Applied Pharmaceutical Science and Medical Science Monitor in 2023.

Her academic excellence extends to language proficiency, having attained an IELTS score of 6.0 in 2023 and undergoing advanced English training at Salahaddin University and AmidEast. She has also attended specialized workshops on Genomics and Proteomics, Infectious Disease Surveillance, and Biomedical Research Techniques, further enriching her expertise.

Impact and Influence 🌍

As an accomplished researcher, Raya has published extensively in renowned scientific journals, making significant contributions to molecular biology, infectious diseases, and neurogenetics. Some of her notable works include:

  • “The miR-146a-5p and miR-125b-5p levels as biomarkers for early prediction of Alzheimer’s disease”
  • “Telomerase Reverse Transcriptase and Telomerase RNA Component Gene Expression as Novel Biomarkers for Alzheimer’s Disease”
  • “The Outbreak of SARS-CoV-2 Variants in Iraqi Kurdistan Region”
  • “Fungal Disease Incidence and Prevalence in Iraq – Preliminary Estimates”
  • “Human ACE and ACE2 Gene Variants and COVID-19 Disease in Iraqi Kurdistan Region” (Accepted for publication)

Her book on microRNAs and telomerase gene expression in Alzheimer’s Disease serves as a valuable resource for researchers exploring neurodegenerative disorders.

Legacy and Future Contributions 🚀

Raya Khalid Yousif’s dedication to research and education positions her as a leading figure in molecular biology and biomedical sciences. With a strong foundation in academia and practical laboratory expertise, she aspires to train future scientists in fields such as molecular microbiology, genetics, clinical immunology, and bioinformatics.

Her unwavering passion for science, coupled with her commitment to humanitarian work—evident in her volunteerism with Together for Human and Environment Association and Community Anti-Drug Collision of Ankawa—reflects her dedication to both scientific and social progress.

Through her relentless pursuit of knowledge and research excellence, Raya continues to pioneer advancements in molecular diagnostics and biomedical research, shaping the future of science and healthcare in Iraq and beyond. 🌟

Publication Top Notes : Molecular biology, Genetics, Neuroscience, Cancer Research

  1. “The miR-146a-5p and miR-125b-5p levels as biomarkers for early prediction of Alzheimer’s disease.”
    • Year: 2022
    • Journal: Human Gene
    • DOI: 10.1016/j.humgen.2022.201129
    • Citations: This study has been referenced in subsequent research exploring microRNA biomarkers in neurodegenerative diseases.
  2. “Telomerase Reverse Transcriptase and Telomerase RNA Component Gene Expression as Novel Biomarkers for Alzheimer’s Disease.”
    • Year: 2022
    • Journal: Cellular and Molecular Biology
    • DOI: 10.14715/cmb/2022.68.9.2
    • Citations: Cited in research focusing on telomerase activity in neurodegenerative conditions.
  3. “Incidence of Candida Species Biofilms in Pediatric Cancer Patients Undergoing Chemotherapy Treatment.”
    • Year: 2022
    • Journal: BioMed Target Journal
    • DOI: 10.59786/bmtj.114
    • Citations: Referenced in studies examining fungal infections in immunocompromised patients.
  4. “Epidemiological Study and Clinical Presentation of Urinary Tract Infection.”
    • Year: 2022
    • Journal: BioMed Target Journal
    • DOI: 10.59786/bmtj.115
    • Citations: Cited in epidemiological research on urinary tract infections.
  5. “MicroRNAs and Telomerase Gene Expression in Alzheimer’s Disease.”
    • Year: 2022
    • Publication Type: Book
    • Link: 978-620-7-47351-9
    • Citations: Serves as a reference in academic discussions on genetic markers in Alzheimer’s disease.
  6. “The Outbreak of SARS-CoV-2 Variants in Iraqi Kurdistan Region.”
    • Year: 2022
    • Journal: The Journal of Infection in Developing Countries
    • DOI: 10.3855/jidc.19351
    • Citations: Included in studies analyzing COVID-19 variant outbreaks.
  7. “Fungal Disease Incidence and Prevalence in Iraq – Preliminary Estimates.”
    • Year: 2024
    • Journal: Journal de Mycologie Médicale
    • DOI: 10.1016/j.mycmed.2024.101516
    • Citations: Referenced in research on fungal disease epidemiology in the Middle East.
  8. “Revolutionizing Medicine: Recent Developments and Future Prospects in Stem Cell Therapy.”
    • Year: 2024
    • Journal: Journal of Stem Cells
    • DOI: 10.1097/JS9.0000000000002109
    • Citations: Cited in discussions on advancements in stem cell research.
  9. “Human ACE and ACE2 Genes Variants and COVID-19 Disease in Iraqi Kurdistan Region.”
    • Year: 2024
    • Journal: Journal of Medical Virology
    • Status: Accepted for publication
    • Citations: Anticipated to contribute to genetic studies related to COVID-19 susceptibility.